Novel half Salphen cobalt(III) complexes: synthesis, DNA binding and anticancer studies
While platinum(II)-based drugs continue to be employed in cancer treatments, the escalating occurrence of severe side effects has spurred researchers to explore novel sources for potential therapeutic agents. Notably, cobalt(III) has emerged as a subject of considerable interest due to its ubiquitou...
Gespeichert in:
| Veröffentlicht in: | Dalton transactions : an international journal of inorganic chemistry Jg. 53; H. 14; S. 6311 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
02.04.2024
|
| ISSN: | 1477-9234, 1477-9234 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | While platinum(II)-based drugs continue to be employed in cancer treatments, the escalating occurrence of severe side effects has spurred researchers to explore novel sources for potential therapeutic agents. Notably, cobalt(III) has emerged as a subject of considerable interest due to its ubiquitous role in human physiology. Several studies investigating the anticancer effects of Salphen complexes derived from cobalt(III) have unveiled intriguing antiproliferative properties. In a bid to enhance our understanding of this class of compounds, we synthesized and characterized two novel half Salphen cobalt(III) complexes. Both compounds exhibited notable stability, even in the presence of physiologically relevant concentrations of glutathione. The application of spectroscopic and computational methodologies unravelled their interactions with duplex and G4-DNAs, suggesting an external binding affinity for these structures, with preliminary indications of selectivity trends. Importantly, antiproliferative assays conducted on 3D cultured SW-1353 cancer cells unveiled a compelling anticancer activity at low micromolar concentrations, underscoring the potential therapeutic efficacy of this novel class of cobalt(III) complexes. |
|---|---|
| AbstractList | While platinum(II)-based drugs continue to be employed in cancer treatments, the escalating occurrence of severe side effects has spurred researchers to explore novel sources for potential therapeutic agents. Notably, cobalt(III) has emerged as a subject of considerable interest due to its ubiquitous role in human physiology. Several studies investigating the anticancer effects of Salphen complexes derived from cobalt(III) have unveiled intriguing antiproliferative properties. In a bid to enhance our understanding of this class of compounds, we synthesized and characterized two novel half Salphen cobalt(III) complexes. Both compounds exhibited notable stability, even in the presence of physiologically relevant concentrations of glutathione. The application of spectroscopic and computational methodologies unravelled their interactions with duplex and G4-DNAs, suggesting an external binding affinity for these structures, with preliminary indications of selectivity trends. Importantly, antiproliferative assays conducted on 3D cultured SW-1353 cancer cells unveiled a compelling anticancer activity at low micromolar concentrations, underscoring the potential therapeutic efficacy of this novel class of cobalt(III) complexes.While platinum(II)-based drugs continue to be employed in cancer treatments, the escalating occurrence of severe side effects has spurred researchers to explore novel sources for potential therapeutic agents. Notably, cobalt(III) has emerged as a subject of considerable interest due to its ubiquitous role in human physiology. Several studies investigating the anticancer effects of Salphen complexes derived from cobalt(III) have unveiled intriguing antiproliferative properties. In a bid to enhance our understanding of this class of compounds, we synthesized and characterized two novel half Salphen cobalt(III) complexes. Both compounds exhibited notable stability, even in the presence of physiologically relevant concentrations of glutathione. The application of spectroscopic and computational methodologies unravelled their interactions with duplex and G4-DNAs, suggesting an external binding affinity for these structures, with preliminary indications of selectivity trends. Importantly, antiproliferative assays conducted on 3D cultured SW-1353 cancer cells unveiled a compelling anticancer activity at low micromolar concentrations, underscoring the potential therapeutic efficacy of this novel class of cobalt(III) complexes. While platinum(II)-based drugs continue to be employed in cancer treatments, the escalating occurrence of severe side effects has spurred researchers to explore novel sources for potential therapeutic agents. Notably, cobalt(III) has emerged as a subject of considerable interest due to its ubiquitous role in human physiology. Several studies investigating the anticancer effects of Salphen complexes derived from cobalt(III) have unveiled intriguing antiproliferative properties. In a bid to enhance our understanding of this class of compounds, we synthesized and characterized two novel half Salphen cobalt(III) complexes. Both compounds exhibited notable stability, even in the presence of physiologically relevant concentrations of glutathione. The application of spectroscopic and computational methodologies unravelled their interactions with duplex and G4-DNAs, suggesting an external binding affinity for these structures, with preliminary indications of selectivity trends. Importantly, antiproliferative assays conducted on 3D cultured SW-1353 cancer cells unveiled a compelling anticancer activity at low micromolar concentrations, underscoring the potential therapeutic efficacy of this novel class of cobalt(III) complexes. |
| Author | Terenzi, Alessio Carreca, Anna Paola Trippodo, Elisa Rubino, Simona Spinello, Angelo Barone, Giampaolo Bonsignore, Riccardo Di Gesù, Roberto |
| Author_xml | – sequence: 1 givenname: Riccardo orcidid: 0000-0003-2699-4384 surname: Bonsignore fullname: Bonsignore, Riccardo email: riccardo.bonsignore@unipa.it organization: Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Università degli Studi di Palermo, Palermo 90128, Italy. riccardo.bonsignore@unipa.it – sequence: 2 givenname: Elisa surname: Trippodo fullname: Trippodo, Elisa email: riccardo.bonsignore@unipa.it organization: Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Università degli Studi di Palermo, Palermo 90128, Italy. riccardo.bonsignore@unipa.it – sequence: 3 givenname: Roberto orcidid: 0000-0001-6196-643X surname: Di Gesù fullname: Di Gesù, Roberto organization: Fondazione Ri.MED, 90133 Palermo, Italy – sequence: 4 givenname: Anna Paola orcidid: 0000-0002-7389-7555 surname: Carreca fullname: Carreca, Anna Paola organization: Fondazione Ri.MED, 90133 Palermo, Italy – sequence: 5 givenname: Simona orcidid: 0000-0002-8911-1414 surname: Rubino fullname: Rubino, Simona email: riccardo.bonsignore@unipa.it organization: Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Università degli Studi di Palermo, Palermo 90128, Italy. riccardo.bonsignore@unipa.it – sequence: 6 givenname: Angelo surname: Spinello fullname: Spinello, Angelo email: riccardo.bonsignore@unipa.it organization: Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Università degli Studi di Palermo, Palermo 90128, Italy. riccardo.bonsignore@unipa.it – sequence: 7 givenname: Alessio orcidid: 0000-0001-9751-1373 surname: Terenzi fullname: Terenzi, Alessio email: riccardo.bonsignore@unipa.it organization: Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Università degli Studi di Palermo, Palermo 90128, Italy. riccardo.bonsignore@unipa.it – sequence: 8 givenname: Giampaolo orcidid: 0000-0001-8773-2359 surname: Barone fullname: Barone, Giampaolo email: riccardo.bonsignore@unipa.it organization: Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Università degli Studi di Palermo, Palermo 90128, Italy. riccardo.bonsignore@unipa.it |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38487871$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtLxDAYRYOMOA_d-AMkyxGspkmbJu6G8VUYxoWKy5ImX6eVNK1NK86_t-AILi73LA53cedo4hoHCJ2H5DokTN6YyPSEEEl3R2gWRkkSSMqiyT-eorn3H4RQSmJ6gqZMRCIRSThD79vmCywulS3wi7JtCQ7rJle2X6Zpejly3Vr4Bn-L_d71JfjKX-G77QrnlTOV22HlzJi-0spp6LDvB1OBP0XHhbIezg69QG8P96_rp2Dz_JiuV5tAM5b0AS8KHZuEcMLzRHNBJOHAJQuLQgiIgOpYRnFkJCExz7kRTOe5MVQKAG24ogu0_N1tu-ZzAN9ndeU1WKscNIPPqIzFaBMWj-rFQR3yGkzWdlWtun32dwb9AahiYcw |
| CitedBy_id | crossref_primary_10_1002_ejic_202400705 crossref_primary_10_1039_D4QI01394H crossref_primary_10_1016_j_inoche_2025_115384 crossref_primary_10_1039_D5NJ01208B crossref_primary_10_3390_molecules30122496 crossref_primary_10_1039_D5MD00323G crossref_primary_10_1007_s00044_024_03309_w crossref_primary_10_1007_s11243_025_00670_6 crossref_primary_10_1016_j_poly_2025_117422 |
| ContentType | Journal Article |
| DBID | NPM 7X8 |
| DOI | 10.1039/d4dt00092g |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1477-9234 |
| ExternalDocumentID | 38487871 |
| Genre | Journal Article |
| GroupedDBID | --- -DZ -~X 0-7 0R~ 29F 4.4 53G 5GY 70~ 7~J AAEMU AAIWI AAJAE AAMEH AANOJ AAWGC AAXHV AAXPP ABASK ABDVN ABEMK ABJNI ABPDG ABRYZ ABXOH ACGFS ACIWK ACLDK ACNCT ADMRA ADSRN AEFDR AENEX AENGV AESAV AETIL AFLYV AFOGI AFRDS AFRZK AFVBQ AGEGJ AGKEF AGRSR AHGCF AKMSF ALMA_UNASSIGNED_HOLDINGS ALUYA ANUXI APEMP ASKNT AUDPV AZFZN BLAPV BSQNT C6K CS3 D0L DU5 EBS ECGLT EE0 EF- F5P GGIMP GNO H13 HZ~ H~N IDZ J3G J3H J3I M4U NPM O9- R56 R7B R7C RAOCF RCNCU RNS RPMJG RRA RRC RSCEA SKA SKF SLH TN5 TWZ UPT VH6 WH7 7X8 AAFBY AGMRB |
| ID | FETCH-LOGICAL-c337t-6ffc5d70606b7c680906e6931ff88e4e2c59454d90056b6d83cbbdd298eecd6a2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001185483200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1477-9234 |
| IngestDate | Sun Nov 09 12:46:03 EST 2025 Mon Jul 21 06:02:56 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 14 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c337t-6ffc5d70606b7c680906e6931ff88e4e2c59454d90056b6d83cbbdd298eecd6a2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-8773-2359 0000-0001-6196-643X 0000-0002-7389-7555 0000-0001-9751-1373 0000-0003-2699-4384 0000-0002-8911-1414 |
| PMID | 38487871 |
| PQID | 2958298035 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2958298035 pubmed_primary_38487871 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-04-02 |
| PublicationDateYYYYMMDD | 2024-04-02 |
| PublicationDate_xml | – month: 04 year: 2024 text: 2024-04-02 day: 02 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Dalton transactions : an international journal of inorganic chemistry |
| PublicationTitleAlternate | Dalton Trans |
| PublicationYear | 2024 |
| SSID | ssj0022052 |
| Score | 2.4799218 |
| Snippet | While platinum(II)-based drugs continue to be employed in cancer treatments, the escalating occurrence of severe side effects has spurred researchers to... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 6311 |
| Title | Novel half Salphen cobalt(III) complexes: synthesis, DNA binding and anticancer studies |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38487871 https://www.proquest.com/docview/2958298035 |
| Volume | 53 |
| WOSCitedRecordID | wos001185483200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UCnrx_agvVvCgYGia3SS7XqRUiwUNBV-9hexLCyWpTSz6793dJHoSBA_JLSE7zG6-mW9mPgBOuPIZJR51EoFMtooRhxFKHORSwTBVyrdaBE-3YRSR4ZAOqoRbXpVV1meiPahFxk2OvOVRX7-SuMi_nLw5RjXKsKuVhMY8aCANZYyfh8NvFsH0kFq2Exua0kO4Hk-KaEtgURh84b38Di3tL6a3-t-PWwMrFbiEndIb1sGcTDfAUrfWdNsEz1E2k2P4mowVvDdttjKF3EwEKU77_f4ZtAXm8kPmFzD_TDU2zEf5ObyKOpCNbPsLTFKhL5MA194yhXlZhrgFHnvXD90bp5JWcDhCYeEESnFfmMk5AQt5QFzqBjKgqK0UIRJLj_sU-1hQMyqUBYIgzpgQeo1SchEk3jZYSLNU7gJIkEZxlIeyLREmwqeirULsCg1skNTBTBMc1zaL9WoNH5GkMnvP4x-rNcFOafh4Us7YiBHRkZQO5vb-8PQ-WPY01LD1NN4BaCi9ceUhWOSzYpRPj6xP6Hs0uPsCrpvAzw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+half+Salphen+cobalt%28III%29+complexes%3A+synthesis%2C+DNA+binding+and+anticancer+studies&rft.jtitle=Dalton+transactions+%3A+an+international+journal+of+inorganic+chemistry&rft.au=Bonsignore%2C+Riccardo&rft.au=Trippodo%2C+Elisa&rft.au=Di+Ges%C3%B9%2C+Roberto&rft.au=Carreca%2C+Anna+Paola&rft.date=2024-04-02&rft.issn=1477-9234&rft.eissn=1477-9234&rft.volume=53&rft.issue=14&rft.spage=6311&rft_id=info:doi/10.1039%2Fd4dt00092g&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-9234&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-9234&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-9234&client=summon |